AI Security and Compliance in Pharmaceuticals
In the fast-evolving landscape of artificial intelligence (AI), the challenges of trust, control, and security present critical barriers to achieving widespread AI adoption. Chief Technical Officers at large pharmaceutical companies are acutely aware of the need to navigate these challenges, particularly in the context of agentic AI systems. As modern AI projects strive for scalability, the unreliability, inefficiency, and lack of control often impede their progress, creating what we refer to as the Trust Gap.
Trustwise, a trailblazer in the realm of AI security and control, offers a powerful solution to address these pressing concerns. Our AI Security and Control Layer, encompassing AI Trust Management for Agentic AI Systems, provides a comprehensive approach to minimize the Trust Gap throughout the entire AI lifecycle. From simulation and verification to optimization and governance, our solutions, embodied in Harmony Ai, empower large organizations to realize AI trust and security at scale.
Hallucination Causes
Hallucinations, defined as sensory perceptions that appear real but are created by the mind, can be profoundly disruptive and alarming. In the context of AI, acknowledging the causes of hallucinations is crucial for CTOs seeking to mitigate the risks associated with agentic AI. Here are some key factors contributing to hallucinations:
Neurological factors: Brain abnormalities, such as epilepsy or migraines, can trigger hallucinations by disrupting normal sensory processing.
Psychiatric conditions: Individuals with schizophrenia, bipolar disorder, or severe depression may experience hallucinations due to disturbances in perception and cognition.
Substance abuse: Consumption of psychoactive substances, including hallucinogens and certain prescription medications, can induce hallucinations.
Sensory deprivation or overload: Extreme sensory experiences, such as prolonged isolation or overwhelming stimulus, can lead to hallucinatory perceptions.
Cognitive biases: Cognitive processes, such as expectation and attention, can influence the occurrence of hallucinations, especially in ambiguous or uncertain situations.
Addressing Hallucination Risks in Agentic AI Systems
As AI systems become more autonomous and agentic, the potential for hallucinations and erroneous perceptions poses a significant concern for CTOs. Trustwise recognizes the imperative to address these risks and offers proactive measures to safeguard agentic AI systems from hallucinatory phenomena:
Real-time security and control: Our solutions embed real-time security, control, and alignment into every agent, ensuring that innovation scales without compromising control. By transforming naked agents into Shielded Agents, we fortify AI systems against the onset of hallucinations.
Trust-as-code delivery: Trustwise delivers trust-as-code through a range of interfaces, including APIs, SDKs, MCPs, and Guardian Agents, providing CTOs with flexible and customizable tools to combat hallucination risks based on their specific needs.
Schedule Demo
Incorporating Trustwise’s AI Security and Control Layer can revolutionize the way large pharmaceutical companies manage the trust and security of their AI systems. To explore our solutions in action and witness firsthand how we can minimize the Trust Gap and mitigate hallucination risks in agentic AI, schedule a demo with Trustwise today.
